Search ( 3940 results )
- article
(Updated on )
Virological Surveillance in France: The Impact of COVID-19 and Future Outlook
Epidemiological surveillance is essential for guiding policymakers toward management measures tailored to the various contexts of a health crisis. In the context of the SARS-CoV-2...
- article
(Updated on )
Focus: Information Systems Put to the Test by COVID-19: Lessons Learned, New Challenges, and Outlook for Preparing for Future Crises
- article
(Updated on )
SurvESMS: A Covid-19 Monitoring System for Social and Medical-Social Institutions
During the spread of the SARS-CoV-2 virus, one of the major challenges of epidemiological surveillance was to obtain up-to-date and comprehensive data on people with COVID-19 in social...
- article
(Updated on )
Monitoring the COVID-19 Pandemic: The SurSaUD® System’s Contribution and Performance
Introduction – When the population-based surveillance phase of the COVID-19 pandemic began in March 2020, the SurSaUD® syndromic surveillance system (Health Surveillance of Emergency...
- article
(Updated on )
Focus: Near-real-time epidemiological surveillance of COVID-19-related hospitalizations in France, 2020–2023: SI-VIC
- article
(Updated on )
Editorial. Information Systems in the Face of the COVID-19 Pandemic: Major Challenges and Lessons Learned
- article
(Updated on )
Description and management measures for cases of invasive Group A streptococcal infections since 2015 and during the 2022–2023 national alert, Auvergne-Rhône-Alpes
Introduction – In response to the resurgence of invasive group A streptococcal infections (IGASIs) in late 2022, healthcare professionals were encouraged to report all hospitalized IGASI...
- article
(Updated on )
The emergence of macrolide resistance in Streptococcus pyogenes or group A beta-hemolytic streptococci.
Streptococcus pyogenes, or group A beta-hemolytic streptococcus (GABHS), is responsible for both localized infections such as sore throats and mild skin infections, as well as severe...
- article
(Updated on )
Susceptibility of Streptococcus pyogenes (SGA) to macrolides and related antibiotics in cases of acute tonsillitis in France, winter 2005–2006
In 2005, the rate of macrolide resistance among GAS was estimated in France to be between 16% and 31%; however, no ad hoc epidemiological study had previously attempted to refine this...
- article
(Updated on )
Reports of invasive nosocomial infections caused by Streptococcus pyogenes in the postoperative or postpartum period in France from August 1, 2001, to December 31, 2003
Streptococcus pyogenes, or group A streptococcus (GAS), is a rare cause of nosocomial infection. In France in 2002, it was isolated in 0.3% of nosocomial bacteremias. The case fatality...
